Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19 - NCT04803227

Number of participants with treatment-related adverse events as assessed by CTCAE v4.0, Patient reported outcomes as assessed by COVID-19 assessment tool, Number of participants that experience death during the study., (and 9 more...)